Related Experiment Videos
Long-term multicentre trial with TA-RO CAP, a new spermicidal product
Contraception
|November 1, 1979
Summary
The TA-RO CAP, a new intravaginal contraceptive, demonstrated effectiveness and tolerability in a three-year clinical trial involving 326 healthy couples. This study provides valuable data on the long-term use of this novel contraceptive method.
Area of Science:
- Reproductive Health
- Contraception Research
- Clinical Trials
Background:
- Intravaginal contraceptives offer an alternative delivery method for birth control.
- Assessing the long-term performance of novel contraceptive devices is crucial for public health.
Purpose of the Study:
- To evaluate the long-term effectiveness of the TA-RO CAP, a new intravaginal contraceptive.
- To assess the tolerability and user acceptance of the TA-RO CAP over a three-year period.
Main Methods:
- A three-year clinical trial involving 326 healthy couples.
- Periodic clinical and laboratory examinations were conducted.
- Life-table analysis was used for statistical evaluation of effectiveness.
Main Results:
- The TA-RO CAP demonstrated effectiveness in preventing pregnancy over the three-year trial period.
- The contraceptive was generally well-tolerated by participants.
- User acceptance data indicated positive reception of the intravaginal device.
Conclusions:
- The TA-RO CAP is a viable long-term contraceptive option.
- Further research may explore wider implementation and specific user demographics.